153 related articles for article (PubMed ID: 36122486)
21. RT-qPCR Assays for Rapid Detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 Mutations: A Screening Strategy to Identify Variants With Clinical Impact.
Vega-Magaña N; Sánchez-Sánchez R; Hernández-Bello J; Venancio-Landeros AA; Peña-Rodríguez M; Vega-Zepeda RA; Galindo-Ornelas B; Díaz-Sánchez M; García-Chagollán M; Macedo-Ojeda G; García-González OP; Muñoz-Valle JF
Front Cell Infect Microbiol; 2021; 11():672562. PubMed ID: 34123874
[TBL] [Abstract][Full Text] [Related]
22. The Prevalence of Protein S Variant in Patients Diagnosed with COVID-19.
Bayirli-Turan D; Usanmaz M; Gorgun S; Yolcu E; Sahin C; Bilenoglu O; Isbilen M; Yildiz E
Clin Lab; 2022 Oct; 68(10):. PubMed ID: 36250839
[TBL] [Abstract][Full Text] [Related]
23. Single-Amplicon Multiplex Real-Time Reverse Transcription-PCR with Tiled Probes To Detect SARS-CoV-2
Babiker A; Immergluck K; Stampfer SD; Rao A; Bassit L; Su M; Nguyen V; Stittleburg V; Ingersoll JM; Bradley HL; Mavigner M; Schoof N; Kraft CS; Chahroudi A; Schinazi RF; Martin GS; Piantadosi A; Lam WA; Waggoner JJ
J Clin Microbiol; 2021 Nov; 59(12):e0144621. PubMed ID: 34432488
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a commercial SARS-CoV-2 multiplex PCR genotyping assay for variant identification in resource-scarce settings.
Umunnakwe CN; Makatini ZN; Maphanga M; Mdunyelwa A; Mlambo KM; Manyaka P; Nijhuis M; Wensing A; Tempelman HA
PLoS One; 2022; 17(6):e0269071. PubMed ID: 35749403
[TBL] [Abstract][Full Text] [Related]
25. Molecular biology of SARS-CoV-2 and techniques of diagnosis and surveillance.
Ishige T
Adv Clin Chem; 2024; 118():35-85. PubMed ID: 38280807
[TBL] [Abstract][Full Text] [Related]
26. Comparison of analytical performance and economic value of two biosurveillance methods for tracking SARS-COV-2 variants of concern.
Pinkhover NP; Pontbriand KM; Fletcher KP; Sanchez E; Okello K; Garvey LM; Pum A; Li K; DeOliveira G; Proctor T; Feenstra JDM; Sorel O; Gandhi M; Auclair JR
Microbiol Spectr; 2024 Feb; 12(2):e0348423. PubMed ID: 38206048
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 multiplex RT-PCR to detect variants of concern (VOCs) in Malaysia, between January to May 2021.
Fu JYL; Chong YM; Sam IC; Chan YF
J Virol Methods; 2022 Mar; 301():114462. PubMed ID: 35026305
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a Rapid and Accessible Reverse Transcription-Quantitative PCR Approach for SARS-CoV-2 Variant of Concern Identification.
Yeung PS; Wang H; Sibai M; Solis D; Yamamoto F; Iwai N; Jiang B; Hammond N; Truong B; Bihon S; Santos S; Mar M; Mai C; Mfuh KO; Miller JA; Huang C; Sahoo MK; Zehnder JL; Pinsky BA
J Clin Microbiol; 2022 May; 60(5):e0017822. PubMed ID: 35465708
[TBL] [Abstract][Full Text] [Related]
29. Emergence of SARS-CoV-2 Variant B.1.575.2, Containing the E484K Mutation in the Spike Protein, in Pamplona, Spain, May to June 2021.
Trobajo-Sanmartín C; Miqueleiz A; Portillo ME; Fernández-Huerta M; Navascués A; Sola Sara P; López Moreno P; Ordoñez GR; Castilla J; Ezpeleta C
J Clin Microbiol; 2021 Nov; 59(12):e0173621. PubMed ID: 34495709
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the clinical and analytical performance of the Seegene allplex™ SARS-CoV-2 variants I assay for the detection of variants of concern (VOC) and variants of interests (VOI).
Caza M; Hogan CA; Jassem A; Prystajecky N; Hadzic A; Wilmer A
J Clin Virol; 2021 Nov; 144():104996. PubMed ID: 34628158
[TBL] [Abstract][Full Text] [Related]
31. Shared Mutations in Emerging SARS-CoV-2 Circulating Variants May Lead to Reverse Transcription-PCR (RT-PCR)-Based Misidentification of B.1.351 and P.1 Variants of Concern.
Losada C; Rico-Luna C; Otero-Sobrino Á; Molero-Salinas A; Buenestado-Serrano S; Candela A; Pérez-Lago L; Muñoz P; Catalán P; de Viedma DG;
Microbiol Spectr; 2021 Oct; 9(2):e0081621. PubMed ID: 34643437
[TBL] [Abstract][Full Text] [Related]
32. Detection of SARS-CoV-2 and the L452R spike mutation using reverse transcription loop-mediated isothermal amplification plus bioluminescent assay in real-time (RT-LAMP-BART).
Iijima T; Ando S; Kanamori D; Kuroda K; Nomura T; Tisi L; Kilgore PE; Percy N; Kohase H; Hayakawa S; Seki M; Hoshino T
PLoS One; 2022; 17(3):e0265748. PubMed ID: 35312732
[TBL] [Abstract][Full Text] [Related]
33. A one-step real-time RT-PCR assay for simultaneous typing of SARS-CoV-2 mutations associated with the E484K and N501Y spike protein amino-acid substitutions.
Chaintoutis SC; Chassalevris T; Tsiolas G; Balaska S; Vlatakis I; Mouchtaropoulou E; Siarkou VI; Tychala A; Koutsioulis D; Skoura L; Argiriou A; Dovas CI
J Virol Methods; 2021 Oct; 296():114242. PubMed ID: 34274369
[TBL] [Abstract][Full Text] [Related]
34. Rapid and qualitative identification of SARS-CoV-2 mutations associated with variants of concern using a multiplex RT-PCR assay coupled with melting analysis.
Sberna G; Fabeni L; Berno G; Carletti F; Specchiarello E; Colavita F; Meschi S; Matusali G; Garbuglia AR; Bordi L; Lalle E
Int J Infect Dis; 2022 Sep; 122():401-404. PubMed ID: 35760381
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 R.1 lineage variants that prevailed in Tokyo in March 2021.
Nagano K; Tani-Sassa C; Iwasaki Y; Takatsuki Y; Yuasa S; Takahashi Y; Nakajima J; Sonobe K; Ichimura N; Nukui Y; Takeuchi H; Tanimoto K; Tanaka Y; Kimura A; Tohda S
J Med Virol; 2021 Dec; 93(12):6833-6836. PubMed ID: 34314050
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 Enzyme.
Fasching CL; Servellita V; McKay B; Nagesh V; Broughton JP; Sotomayor-Gonzalez A; Wang B; Brazer N; Reyes K; Streithorst J; Deraney RN; Stanfield E; Hendriks CG; Fung B; Miller S; Ching J; Chen JS; Chiu CY
J Clin Microbiol; 2022 Jul; 60(7):e0026122. PubMed ID: 35766492
[TBL] [Abstract][Full Text] [Related]
37. Identification of SARS-CoV-2 Variants of Concern Using Amplicon Next-Generation Sequencing.
Nasereddin A; Golan Berman H; Wolf DG; Oiknine-Djian E; Adar S
Microbiol Spectr; 2022 Aug; 10(4):e0073622. PubMed ID: 35758686
[TBL] [Abstract][Full Text] [Related]
38. Detection of Major SARS-CoV-2 Variants of Concern in Clinical Samples via CRISPR-Cas12a-Mediated Mutation-Specific Assay.
Liang Y; Zou L; Lin H; Li B; Zhao J; Wang H; Sun J; Chen J; Mo Y; Yang X; Deng X; Tang S
ACS Synth Biol; 2022 May; 11(5):1811-1823. PubMed ID: 35481381
[No Abstract] [Full Text] [Related]
39. The Rapid Antigen Detection Test for SARS-CoV-2 Underestimates the Identification of COVID-19 Positive Cases and Compromises the Diagnosis of the SARS-CoV-2 (K417N/T, E484K, and N501Y) Variants.
Barrera-Avalos C; Luraschi R; Vallejos-Vidal E; Mella-Torres A; Hernández F; Figueroa M; Rioseco C; Valdés D; Imarai M; Acuña-Castillo C; Reyes-López FE; Sandino AM
Front Public Health; 2021; 9():780801. PubMed ID: 35047474
[TBL] [Abstract][Full Text] [Related]
40. A novel diagnostic test to screen SARS-CoV-2 variants containing E484K and N501Y mutations.
Zhao Y; Lee A; Composto K; Cunningham MH; Mediavilla JR; Fennessey S; Corvelo A; Chow KF; Zody M; Chen L; Kreiswirth BN; Perlin DS
Emerg Microbes Infect; 2021 Dec; 10(1):994-997. PubMed ID: 33977858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
